NFJ Investment Group LLC lowered its holdings in shares of The Allstate Co. (NYSE:ALL – Free Report) by 2.2% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 60,737 shares of the insurance provider’s stock after selling 1,380 shares during the quarter. NFJ Investment Group LLC’s holdings in Allstate were worth $11,519,000 as of its most recent SEC filing.
Several other hedge funds also recently bought and sold shares of ALL. IHT Wealth Management LLC lifted its holdings in Allstate by 5.7% during the 3rd quarter. IHT Wealth Management LLC now owns 4,263 shares of the insurance provider’s stock valued at $809,000 after buying an additional 229 shares in the last quarter. Integrated Wealth Concepts LLC raised its stake in shares of Allstate by 108.9% during the third quarter. Integrated Wealth Concepts LLC now owns 6,818 shares of the insurance provider’s stock valued at $1,293,000 after acquiring an additional 3,554 shares in the last quarter. Investment Management Corp of Ontario boosted its holdings in shares of Allstate by 49.1% in the third quarter. Investment Management Corp of Ontario now owns 8,801 shares of the insurance provider’s stock valued at $1,669,000 after purchasing an additional 2,900 shares during the period. Janus Henderson Group PLC grew its stake in Allstate by 1.1% in the third quarter. Janus Henderson Group PLC now owns 32,315 shares of the insurance provider’s stock worth $6,127,000 after purchasing an additional 347 shares in the last quarter. Finally, Hilltop Holdings Inc. increased its holdings in Allstate by 25.1% during the 3rd quarter. Hilltop Holdings Inc. now owns 2,683 shares of the insurance provider’s stock worth $509,000 after purchasing an additional 539 shares during the period. Institutional investors own 76.47% of the company’s stock.
Insiders Place Their Bets
In related news, insider John E. Dugenske sold 36,367 shares of the firm’s stock in a transaction on Friday, September 20th. The shares were sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the sale, the insider now owns 27,364 shares in the company, valued at approximately $5,236,922.32. This trade represents a 57.06 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.80% of the stock is owned by insiders.
Allstate Stock Performance
Allstate (NYSE:ALL – Get Free Report) last released its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, topping analysts’ consensus estimates of $2.20 by $1.71. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The firm had revenue of $16.63 billion during the quarter, compared to the consensus estimate of $14.57 billion. During the same quarter in the previous year, the company posted $0.81 earnings per share. The company’s revenue was up 14.7% compared to the same quarter last year. Research analysts predict that The Allstate Co. will post 16.26 EPS for the current fiscal year.
Allstate Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, January 2nd. Shareholders of record on Friday, November 29th will be issued a $0.92 dividend. This represents a $3.68 annualized dividend and a yield of 1.81%. The ex-dividend date is Friday, November 29th. Allstate’s payout ratio is 23.83%.
Analyst Upgrades and Downgrades
Several equities analysts have recently commented on ALL shares. Raymond James raised their price target on Allstate from $205.00 to $220.00 and gave the company a “strong-buy” rating in a research note on Friday, October 4th. UBS Group boosted their price target on shares of Allstate from $216.00 to $225.00 and gave the company a “buy” rating in a report on Monday, November 4th. Wells Fargo & Company increased their price objective on shares of Allstate from $175.00 to $186.00 and gave the company an “equal weight” rating in a research note on Tuesday, November 5th. Morgan Stanley upped their target price on Allstate from $220.00 to $228.00 and gave the stock an “overweight” rating in a report on Thursday, November 7th. Finally, Evercore ISI boosted their price target on Allstate from $191.00 to $195.00 and gave the stock an “in-line” rating in a research report on Wednesday, October 9th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $217.19.
Check Out Our Latest Stock Analysis on ALL
About Allstate
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Read More
- Five stocks we like better than Allstate
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
- The How and Why of Investing in Gold Stocks
- 3 S&P 500 Stocks With Sky High Risk-Adjusted Returns
- Insider Trades May Not Tell You What You Think
- Trending Stocks: How to Spot, Trade, and Profit Safely
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.